Company page
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. is a public company traded under the ticker STOK in the American market. The company has a market capitalization of approximately $1.93 billion. Stoke Therapeutics focuses on developing innovative therapies to treat genetic diseases by addressing the underlying causes of these conditions.
- Ticker
- STOK:NASDAQ
- Asset type
- Stock
- Market cap
- $1.93B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD